From Mushrooms to Myolysis
Mariella Suleiman, Arnabh Basu, Sameen Belal, Theresa Jacob
The Journal of Nervous and Mental Disease July 29, 2022 DOI: 10.1097/nmd.0000000000001489 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A young patient who used a large amount of psilocybin |
| Intervention | Psilocybin |
| Dose | a large amount |
| Topics | Psilocybin |
| Keywords | Hallucinogen Psychosis Recreational drug Vigilance psychology Paranoia Amphetamine |
| Citations | 8 |
| Key findings | Psilocybin use in a young patient was associated with a first psychotic and manic episode, violent behavior, and rhabdomyolysis. |
Abstract
Abstract The involvement of certain recreational drugs, namely, hallucinogens, in the development of hyperactive syndromes is well known, but not well studied. In this report, we expand on this relationship by documenting the development of substance-induced psychosis in a young patient who used a large amount of psilocybin and developed symptoms of a first psychotic and manic episode, complicated by violent behavior and rhabdomyolysis. We further evaluate the association between psilocybin use and rhabdomyolysis and explore this understudied phenomenon and differentiate it from the diagnoses of other hyperactive syndromes seen in psychiatry. This case exemplifies the need for increased vigilance in psilocybin microdosing therapy and for physicians to be mindful of how each patient responds to its use to prevent life-threatening hyperactive syndromes in its wake.
Comparable studies
Other case reports and case series on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin Mushroom (Psilocybe semilanceata) Intoxication with Myocardial Infarction 18-year-old man | 1998 | Case study | n = 1 |
| Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF) Person with leg amputation and phantom-limb pain | 2018 | Case study | n = 1 |
| Hallucinogen persisting perception disorder after psilocybin consumption: a case study 18-year-old man with HPPD after mixed psilocybin and cannabis intoxication | 2005 | Case study | n = 1 |
| Microdosing psilocybin for chronic pain: a case series Individuals with chronic neuropathic pain | 2022 | Case series | n = 3 |
| Psilocybin and Obsessive Compulsive Disorder Individual with Obsessive Compulsive Disorder | 2014 | Case study | n = 1 |
Citations in the library
Cited by 7
- Psilocybin for the treatment of Alzheimer’s disease Frontiers in Neuroscience July 10, 2024
- Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports. Psychological Medicine November 20, 2024
- Psychedelics, With a Focus on Psilocybin: Issues for the Clinician. Journal of Psychiatric Practice September 1, 2023
- Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review. Current Topics in Behavioral Neurosciences October 23, 2024
- A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient Clinical Psychopharmacology and Neuroscience May 21, 2024
and 2 more in the library
Cites 5
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
- Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder The Journal of Clinical Psychiatry November 15, 2006
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies Journal of Psychopharmacology September 20, 2010
- Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis Schizophrenia Bulletin October 6, 2012
- Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016 Journal of Psychopharmacology September 5, 2018